US 11,744,943 B2
Integrated insulin delivery system with continuous glucose sensor
John Michael Dobbles, San Clemente, CA (US); Apurv Ullas Kamath, San Diego, CA (US); Aarthi Mahalingam, San Diego, CA (US); and James H. Brauker, Addison, MI (US)
Assigned to DexCom, Inc., San Diego, CA (US)
Filed by DexCom, Inc., San Diego, CA (US)
Filed on Apr. 17, 2020, as Appl. No. 16/852,369.
Application 16/852,369 is a continuation of application No. 15/792,038, filed on Oct. 24, 2017, granted, now 10,653,835.
Application 15/792,038 is a continuation of application No. 15/362,571, filed on Nov. 28, 2016, granted, now 9,827,372.
Application 15/362,571 is a continuation of application No. 14/063,811, filed on Oct. 25, 2013, granted, now 9,597,453.
Application 14/063,811 is a continuation of application No. 13/885,604, granted, now 9,452,258, previously published as PCT/US2007/080848, filed on Oct. 9, 2007.
Prior Publication US 2020/0330684 A1, Oct. 22, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. A61M 5/172 (2006.01); A61B 5/145 (2006.01); A61M 5/142 (2006.01); A61M 11/00 (2006.01); A61M 15/00 (2006.01); G16H 40/63 (2018.01); G16H 20/17 (2018.01); A61M 35/00 (2006.01); A61M 5/20 (2006.01); A61B 5/00 (2006.01); A61M 5/00 (2006.01); A61M 5/178 (2006.01); A61M 5/30 (2006.01)
CPC A61M 5/1723 (2013.01) [A61B 5/14532 (2013.01); A61B 5/14546 (2013.01); A61M 5/14244 (2013.01); A61M 5/14276 (2013.01); A61M 5/20 (2013.01); A61M 11/00 (2013.01); A61M 15/008 (2014.02); A61M 15/0065 (2013.01); A61M 15/0068 (2014.02); A61M 15/0083 (2014.02); A61M 35/00 (2013.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01); A61B 5/0031 (2013.01); A61M 5/003 (2013.01); A61M 5/178 (2013.01); A61M 5/30 (2013.01); A61M 15/00 (2013.01); A61M 2005/14296 (2013.01); A61M 2205/3569 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2205/581 (2013.01); A61M 2205/582 (2013.01); A61M 2205/587 (2013.01); A61M 2205/8206 (2013.01); A61M 2230/201 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method for diabetes management, the method comprising:
controlling insulin delivery to a host, using a processor comprising a controller module;
iteratively evaluating internally derived data relative to a predetermined glucose boundary; and
selectively turning the controller module on or off responsive to the iterative evaluation.